Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Diffuse interstitial lung disorders in systemic diseases].

J C Kips1

  • 1Dienst Medische Genetica-UGent De Pintelaan 185-B 9000 Gent.

Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie
|February 18, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of Theophylline on Endotoxin and Tumor Necrosis Factor Induced Airway Changes in an in vivo Animal Model.

International archives of allergy and immunology·2021
Same author

[The relation between morphologic and functional airway changes in bronchial asthma].

Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie·2003
Same author

Murine models of asthma.

The European respiratory journal·2003
Same author

Dose-related effect of inhaled fluticasone on allergen-induced airway changes in rats.

The European respiratory journal·2002
Same author

Cytokines in asthma.

The European respiratory journal. Supplement·2002
Same author

Clinical applications of assessment of airway inflammation using induced sputum.

The European respiratory journal. Supplement·2002

Diffuse parenchymal lung disorders (DPLD) encompass conditions like sarcoidosis, systemic sclerosis, and Churg Strauss vasculitis. Early diagnosis and targeted treatment are crucial for managing these complex systemic diseases affecting the lungs.

Area of Science:

  • Pulmonary Medicine
  • Rheumatology
  • Pathology

Context:

  • Diffuse parenchymal lung disorders (DPLD) are associated with various systemic conditions.
  • This review highlights sarcoidosis, systemic sclerosis, and Churg Strauss vasculitis as key examples.
  • Pulmonary involvement is a significant manifestation across these systemic diseases.

Purpose:

  • To provide an overview of DPLD associated with systemic disorders.
  • To discuss the clinical presentation, diagnosis, and management of sarcoidosis, systemic sclerosis, and Churg Strauss vasculitis.
  • To emphasize the importance of recognizing pulmonary manifestations in systemic diseases.

Summary:

  • Sarcoidosis diagnosis relies on clinical, radiological, and histological findings (non-caseating epitheloid granulomas); steroid treatment is reserved for functional impairment.

Related Experiment Videos

  • Systemic sclerosis frequently causes lung fibrosis (UIP/NSIP patterns), stemming from autoimmune-mediated lung injury and abnormal repair.
  • Churg Strauss vasculitis presents with asthma, eosinophilia, and small vessel vasculitis, with potential pANCA involvement.

    • Impact:

    • Enhances understanding of DPLD in systemic diseases.
    • Informs clinical diagnosis and management strategies for affected patients.
    • Highlights the need for multidisciplinary approaches in managing complex lung disorders.